Lazo-Langner A, Louzada M, Garg A, et al. Assessing the risk-benefit of anticoagulants in elkderly patients with cancer-associated venous thromboembolism; a population based study. EHA 2017, abstract S441.
Hyper-CVAD plus ofatumumab als eerstelijnsbehandeling bij Ph-negatieve B-cel ALL
aug 2020 | Leukemie